EPAD publishes its LCS study protocol
The EPAD project aims to develop an environment for and then test multiple different interventions targeting the secondary prevention of Alzheimer’s disease dementia. EPAD is conducting a Longitudinal Cohort…
EPAD welcomes new partner MSD
We are pleased to announce the arrival of a new project partner, MSD (Merck Sharp and Dohme). We say a warm welcome to MSD and look forward to our collaboration.…
Spotlight on Brescia
The EPAD family of trial delivery centres grew to 20 sites in August 2018 with Brescia (Italy) enrolling its first research participant. The team of Dr. Samantha Galluzzi (principal investigator…
Aridhia announces its partnership with Microsoft Azure
On 4 December, our partner Aridhia announced that its digital research platform AnalytiXagility used in the health, biomedical research and precision medicine sectors, is to move all its work to Azure, including…